209 related articles for article (PubMed ID: 26483416)
21. Estrogen receptor beta (ERβ) mediates expression of β-catenin and proliferation in prostate cancer cell line PC-3.
Lombardi AP; Pisolato R; Vicente CM; Lazari MF; Lucas TF; Porto CS
Mol Cell Endocrinol; 2016 Jul; 430():12-24. PubMed ID: 27107935
[TBL] [Abstract][Full Text] [Related]
22. Estrogen receptor alpha and beta heterodimers exert unique effects on estrogen- and tamoxifen-dependent gene expression in human U2OS osteosarcoma cells.
Monroe DG; Secreto FJ; Subramaniam M; Getz BJ; Khosla S; Spelsberg TC
Mol Endocrinol; 2005 Jun; 19(6):1555-68. PubMed ID: 15802376
[TBL] [Abstract][Full Text] [Related]
23. Fulvestrant-mediated inhibition of estrogen receptor signaling slows lung cancer progression.
Tang H; Liao Y; Zhang C; Chen G; Xu L; Liu Z; Fu S; Yu L; Zhou S
Oncol Res; 2014; 22(1):13-20. PubMed ID: 25700354
[TBL] [Abstract][Full Text] [Related]
24. A comparative characterization of estrogens used in hormone therapy via estrogen receptor (ER)-α and -β.
Perkins MS; Louw-du Toit R; Africander D
J Steroid Biochem Mol Biol; 2017 Nov; 174():27-39. PubMed ID: 28743541
[TBL] [Abstract][Full Text] [Related]
25. HOXC6 Is transcriptionally regulated via coordination of MLL histone methylase and estrogen receptor in an estrogen environment.
Ansari KI; Hussain I; Shrestha B; Kasiri S; Mandal SS
J Mol Biol; 2011 Aug; 411(2):334-49. PubMed ID: 21683083
[TBL] [Abstract][Full Text] [Related]
26. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.
Williams C; Edvardsson K; Lewandowski SA; Ström A; Gustafsson JA
Oncogene; 2008 Feb; 27(7):1019-32. PubMed ID: 17700529
[TBL] [Abstract][Full Text] [Related]
27. Cyclin D1 (CCND1) expression is involved in estrogen receptor beta (ERβ) in human prostate cancer.
Nakamura Y; Felizola SJ; Kurotaki Y; Fujishima F; McNamara KM; Suzuki T; Arai Y; Sasano H
Prostate; 2013 May; 73(6):590-5. PubMed ID: 23060014
[TBL] [Abstract][Full Text] [Related]
28. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
[TBL] [Abstract][Full Text] [Related]
29. Binding of estrogen receptor beta to estrogen response element in situ is independent of estradiol and impaired by its amino terminus.
Huang J; Li X; Maguire CA; Hilf R; Bambara RA; Muyan M
Mol Endocrinol; 2005 Nov; 19(11):2696-712. PubMed ID: 15976006
[TBL] [Abstract][Full Text] [Related]
30. Estrogen inhibits renal cell carcinoma cell progression through estrogen receptor-β activation.
Yu CP; Ho JY; Huang YT; Cha TL; Sun GH; Yu DS; Chang FW; Chen SP; Hsu RJ
PLoS One; 2013; 8(2):e56667. PubMed ID: 23460808
[TBL] [Abstract][Full Text] [Related]
31. Cytochrome P450 1A2 Metabolizes 17β-Estradiol to Suppress Hepatocellular Carcinoma.
Ren J; Chen GG; Liu Y; Su X; Hu B; Leung BC; Wang Y; Ho RL; Yang S; Lu G; Lee CG; Lai PB
PLoS One; 2016; 11(4):e0153863. PubMed ID: 27093553
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of estrogen receptor β in breast and prostate cancer from biological aspects.
Omoto Y; Iwase H
Cancer Sci; 2015 Apr; 106(4):337-43. PubMed ID: 25611678
[TBL] [Abstract][Full Text] [Related]
33. 17β-estradiol represses myogenic differentiation by increasing ubiquitin-specific peptidase 19 through estrogen receptor α.
Ogawa M; Yamaji R; Higashimura Y; Harada N; Ashida H; Nakano Y; Inui H
J Biol Chem; 2011 Dec; 286(48):41455-41465. PubMed ID: 21971047
[TBL] [Abstract][Full Text] [Related]
34. 17beta-estradiol up-regulates the insulin-like growth factor receptor through a nongenotropic pathway in prostate cancer cells.
Pandini G; Genua M; Frasca F; Squatrito S; Vigneri R; Belfiore A
Cancer Res; 2007 Sep; 67(18):8932-41. PubMed ID: 17875736
[TBL] [Abstract][Full Text] [Related]
35. Differential effects of estrogen-dependent transactivation vs. transrepression by the estrogen receptor on invasiveness of HER2 overexpressing breast cancer cells.
Patki M; Salazar Md; Trumbly R; Ratnam M
Biochem Biophys Res Commun; 2015 Feb; 457(3):404-11. PubMed ID: 25582774
[TBL] [Abstract][Full Text] [Related]
36. 17β-estradiol upregulates IL6 expression through the ERβ pathway to promote lung adenocarcinoma progression.
Huang Q; Zhang Z; Liao Y; Liu C; Fan S; Wei X; Ai B; Xiong J
J Exp Clin Cancer Res; 2018 Jul; 37(1):133. PubMed ID: 29970138
[TBL] [Abstract][Full Text] [Related]
37. Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells.
Kallio A; Guo T; Lamminen E; Seppänen J; Kangas L; Väänänen HK; Härkönen P
Mol Cell Endocrinol; 2008 Jul; 289(1-2):38-48. PubMed ID: 18455292
[TBL] [Abstract][Full Text] [Related]
38. Essential role for estrogen receptor beta in stromal-epithelial regulation of prostatic hyperplasia.
McPherson SJ; Ellem SJ; Simpson ER; Patchev V; Fritzemeier KH; Risbridger GP
Endocrinology; 2007 Feb; 148(2):566-74. PubMed ID: 17068134
[TBL] [Abstract][Full Text] [Related]
39. Modulators of estrogen receptor inhibit proliferation and migration of prostate cancer cells.
Piccolella M; Crippa V; Messi E; Tetel MJ; Poletti A
Pharmacol Res; 2014 Jan; 79():13-20. PubMed ID: 24184124
[TBL] [Abstract][Full Text] [Related]
40. Estrogen receptor β-dependent Notch1 activation protects vascular endothelium against tumor necrosis factor α (TNFα)-induced apoptosis.
Fortini F; Vieceli Dalla Sega F; Caliceti C; Aquila G; Pannella M; Pannuti A; Miele L; Ferrari R; Rizzo P
J Biol Chem; 2017 Nov; 292(44):18178-18191. PubMed ID: 28893903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]